Bal Pharma Ltd Files Annual Report 2026
Bal Pharma Limited has submitted its Annual Report for the fiscal year 2025-26, in compliance with SEBI Listing Regulations. The report, along with the notice for the 39th Annual General Meeting (AGM), is being circulated to shareholders. For members without registered email IDs, a letter with a web link to access the report online is being dispatched. The annual report is available on the company's website, www.balpharma.com, and details the company's commitment to quality healthcare and its vision for a healthier future. The filing also lists the Board of Directors, Key Management Personnel (KMPs), and various committees, along with statutory, secretarial, internal, and cost auditors, and the Registrar & Transfer Agents.
Key Highlights
- Annual Report 2025-26 filed as per SEBI Listing Regulations.
- Notice for the 39th AGM also circulated to members.
- Annual report accessible via company website and direct link.
- Details Board of Directors, KMPs, and auditors provided.
- Company reiterates commitment to quality healthcare.
Price Impact
More from BALPHARMA